Facilitation Through Abciximab By drOpping Infusion Line in Patients Undergoing Coronary Stenting. SYNergy With Clopidogrel at High Loading dOse Regimen.

Trial Profile

Facilitation Through Abciximab By drOpping Infusion Line in Patients Undergoing Coronary Stenting. SYNergy With Clopidogrel at High Loading dOse Regimen.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Aug 2011

At a glance

  • Drugs Abciximab; Clopidogrel
  • Indications Acute coronary syndromes; Coronary stent thrombosis
  • Focus Pharmacodynamics
  • Acronyms FABOLUS
  • Most Recent Events

    • 10 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top